Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.
Int J Cancer. 2011 Sep 1;129(5):1225-36. doi: 10.1002/ijc.26045. Epub 2011 Apr 27.
Despite fertility-preserving initiatives, postcancer reproduction is expected to be lower than that of the general population. Using data from the Cancer Registry and the Medical Birth Registry of Norway, postcancer pregnancy rates were analyzed in 27,556 survivors and compared to those from a matched comparison group ("controls") from the general population. All were born after 1950, diagnosed from 1967 to 2004 at age of 16-45, and had an observation time from the date of diagnosis (assigned date for controls), until pregnancy, death, age 46, or December 31, 2006. Cox regression was used to estimate pregnancy rates, after adjusting for educational level, parity and diagnostic period. Overall, cancer survivors had a lower pregnancy rate than the controls, but the rate for survivors was higher in males than in females [hazard rate (HR)=0.74 (95% confidence interval (CI) 0.71-0.78) and HR=0.61 (95% CI 0.58-0.64), respectively]. However, the rates did not differ between controls and survivors of malignant melanoma or thyroid cancer. By contrast, the lowest HRs for pregnancy occurred in survivors of leukemia, cervical or breast cancer. Increased pregnancy rates during the study period were detected for ovarian cancer [HR=0.2 (95% CI 0.1-0.3) to HR=0.7 (95% CI 0.5-0.9)], testicular cancer [HR=0.6 (95% CI 0.4-0.9) to HR=0.8 (95% CI 0.7-0.8)], and Hodgkin lymphoma diagnosed in men [HR=0.7 (95% CI 0.5-0.9) to HR=0.9 (95% CI 0.7-1.0)]. In summary, fertility-preserving attempts have succeeded in patients with ovarian or testicular cancer and in males with Hodgkin lymphoma. Male survivors initiated pregnancies in a higher degree than female survivors.
尽管采取了生育保护措施,但癌症患者的生育能力仍预计低于普通人群。本研究利用挪威癌症登记处和医学出生登记处的数据,对 27556 例癌症幸存者的妊娠率进行了分析,并与普通人群中匹配的对照组(“对照组”)进行了比较。所有患者均于 1950 年后出生,1967 年至 2004 年期间确诊,年龄在 16-45 岁之间,自诊断日期(对照组的指定日期)开始观察,直至妊娠、死亡、46 岁或 2006 年 12 月 31 日。采用 Cox 回归估计妊娠率,调整了教育水平、产次和诊断期等因素。总体而言,癌症幸存者的妊娠率低于对照组,但男性幸存者的妊娠率高于女性幸存者[危险比(HR)=0.74(95%置信区间(CI)0.71-0.78)和 HR=0.61(95% CI 0.58-0.64)]。然而,恶性黑色素瘤或甲状腺癌幸存者与对照组之间的妊娠率没有差异。相比之下,白血病、宫颈癌或乳腺癌幸存者的妊娠率最低。卵巢癌患者的妊娠率在研究期间有所增加[HR=0.2(95% CI 0.1-0.3)至 HR=0.7(95% CI 0.5-0.9)],睾丸癌[HR=0.6(95% CI 0.4-0.9)至 HR=0.8(95% CI 0.7-0.8)]和男性霍奇金淋巴瘤[HR=0.7(95% CI 0.5-0.9)至 HR=0.9(95% CI 0.7-1.0)]。总之,生育保护措施在卵巢癌或睾丸癌患者以及男性霍奇金淋巴瘤患者中取得了成功。男性幸存者比女性幸存者更倾向于开始妊娠。